Keywords: pfizer, take, 3rd-qtr, 369m, charge, relating, legacy

Pfizer to take 3rd-qtr $369M charge relating to legacy asbestos claims

Article | 13 September 2004

Print This

World drug leader Pfizer has said it will take a $369 million pretax($229 million after tax) charge in the third quarter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in